Patents by Inventor Kocherlakota Chandrashekhar

Kocherlakota Chandrashekhar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11865180
    Abstract: The present invention relates to novel oral spray formulations of Levothyroxine. Further the invention also describes process for preparing such formulations.
    Type: Grant
    Filed: April 28, 2022
    Date of Patent: January 9, 2024
    Assignee: LEIUTIS PHARMACEUTICALS LLP
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • Publication number: 20220249362
    Abstract: The present invention relates to novel oral spray formulations of Levothyroxine. Further the invention also describes process for preparing such formulations.
    Type: Application
    Filed: April 28, 2022
    Publication date: August 11, 2022
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Patent number: 11364196
    Abstract: The present invention relates to novel oral spray formulations of Levothyroxine. Further the invention also describes process for preparing such formulations.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: June 21, 2022
    Assignee: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • Publication number: 20220047509
    Abstract: The present invention relates to stabilized liquid formulations of Levothyroxine or a pharmaceutically acceptable salt thereof, intended for parenteral administration. Further this invention also describes process of preparing such compositions.
    Type: Application
    Filed: October 5, 2021
    Publication date: February 17, 2022
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Patent number: 11154498
    Abstract: The present invention relates to stabilized liquid formulations of Levothyroxine or a pharmaceutically acceptable salt thereof, intended for parenteral administration. Further this invention also describes process of preparing such compositions.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: October 26, 2021
    Assignee: Leiutis Pharmaceuticals PVT. LTD.
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • Publication number: 20210220375
    Abstract: The present invention relates to stable ready to use liquid formulations of Cyclophosphamide for parenteral use. The ready to use composition comprises Cyclophosphamide dissolved in a solvent system comprising a solvent, cosolvent(s) and antioxidant(s).
    Type: Application
    Filed: April 6, 2021
    Publication date: July 22, 2021
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda Nagaraju
  • Patent number: 10993952
    Abstract: The present invention relates to stable ready to use liquid formulations of Cyclophosphamide for parenteral use. The ready to use composition comprises Cyclophosphamide dissolved in a solvent system comprising a solvent, cosolvent(s) and antioxidant(s).
    Type: Grant
    Filed: February 15, 2016
    Date of Patent: May 4, 2021
    Assignee: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • Publication number: 20200188368
    Abstract: The disclosure relates to chemotherapy treatments and in particular, formulations for antiemetic therapy. Parenteral formulations comprising Palonosetron, NK1 receptor antagonist and a corticosteroid is provided. Also provided is a process of preparing such formulations.
    Type: Application
    Filed: February 20, 2020
    Publication date: June 18, 2020
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • Publication number: 20200188406
    Abstract: The present invention relates to liquid formulations of Fosaprepitant intended for parenteral administration. Further the invention also describes process for preparing such formulations.
    Type: Application
    Filed: February 26, 2020
    Publication date: June 18, 2020
    Applicant: Leiutis Pharmaceuticals PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Patent number: 10610532
    Abstract: The present invention relates to liquid formulations of Fosaprepitant intended for parenteral administration. Further the invention also describes process for preparing such formulations.
    Type: Grant
    Filed: August 2, 2016
    Date of Patent: April 7, 2020
    Assignee: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • Publication number: 20200085731
    Abstract: The present invention relates to stable, liquid parenteral formulations of Melphalan or pharmaceutically acceptable salts thereof. Further this invention also describes process of preparing such formulations.
    Type: Application
    Filed: November 25, 2019
    Publication date: March 19, 2020
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Patent number: 10537520
    Abstract: The present invention relates to stable, liquid parenteral formulations of Melphalan or pharmaceutically acceptable salts thereof. Further this invention also describes process of preparing such formulations.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: January 21, 2020
    Assignee: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • Publication number: 20190240247
    Abstract: The present invention relates to parenteral pharmaceutical formulation of Regadenoson comprising of Regadenoson, one or more cyclodextrins and pharmaceutically acceptable excipients.
    Type: Application
    Filed: August 31, 2017
    Publication date: August 8, 2019
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Publication number: 20190224202
    Abstract: The present invention provides a stable ready to use liquid parenteral formulations of Pemetrexed or a pharmaceutically acceptable salt thereof. Further this invention also describes process of preparing such formulations.
    Type: Application
    Filed: June 9, 2016
    Publication date: July 25, 2019
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Publication number: 20190151234
    Abstract: The present invention relates to stable liquid pharmaceutical formulation of Bendamustine or a pharmaceutically acceptable salt thereof; wherein the formulation is devoid of propylene glycol.
    Type: Application
    Filed: March 30, 2017
    Publication date: May 23, 2019
    Applicant: Leiutis Pharmaceuticals Pvt. Ltd.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Publication number: 20190060217
    Abstract: The present invention relates to novel oral spray formulations of Levothyroxine. Further the invention also describes process for preparing such formulations.
    Type: Application
    Filed: November 3, 2016
    Publication date: February 28, 2019
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Publication number: 20180235973
    Abstract: The present invention relates to liquid formulations of Fosaprepitant intended for parenteral administration. Further the invention also describes process for preparing such formulations.
    Type: Application
    Filed: August 2, 2016
    Publication date: August 23, 2018
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Publication number: 20180214374
    Abstract: The present invention relates to stabilized liquid formulations of Levothyroxine or a pharmaceutically acceptable salt thereof, intended for parenteral administration. Further this invention also describes process of preparing such compositions.
    Type: Application
    Filed: July 20, 2016
    Publication date: August 2, 2018
    Inventors: Kocherlakota Chandrashekhar, Banda Nagaraju
  • Publication number: 20180193255
    Abstract: The present invention relates to stable, liquid parenteral formulations of Melphalan or pharmaceutically acceptable salts thereof. Further this invention also describes process of preparing such formulations.
    Type: Application
    Filed: June 29, 2016
    Publication date: July 12, 2018
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU
  • Publication number: 20180110822
    Abstract: The present invention relates to stable liquid pharmaceutical compositions of Bortezomib or a pharmaceutically acceptable salt thereof. Further the present invention relates to liquid parenteral formulations of Bortezomib comprising of Bortezomib, one or more solvents and other pharmaceutically acceptable adjuvants thereof.
    Type: Application
    Filed: April 12, 2016
    Publication date: April 26, 2018
    Applicant: LEIUTIS PHARMACEUTICALS PVT. LTD.
    Inventors: Kocherlakota CHANDRASHEKHAR, Banda NAGARAJU